Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10969325 | Vaccine | 2011 | 4 Pages |
Abstract
Our findings indicate that the prevalence of seroprotective levels of anti-HBs detected eleven years after primary immunization as well as the frequency of response to a booster dose of vaccine are lower in celiac patients compared to healthy controls.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
F. Zingone, F. Morisco, A. Zanetti, L. Romanò, G. Portella, P. Capone, P. Andreozzi, R. Tortora, C. Ciacci,